Long-Term Safety Study of TA-7284 in Patients With Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of TA-7284 as monotherapy or
combination therapy with other oral anti-hyperglycaemic agent in Japanese patients with Type
2 diabetes mellitus on 52 weeks oral administration.